Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03294590 · ClinicalTrials.gov registry record · NA
Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 754
- Enrollment target
NCT03294590 is a NA study that has completed, run by Boston University. The registered enrollment target is 754 participants.
The verdict
NCT03294590, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 754 participants
- Enrollment target
Study Summary
This is a randomized clinical trial to test the efficacy of a parent-targeted text message-based intervention program on caries incidence and oral health behaviors (child and parent). Parents (n= 850) across all pediatric clinic sites (Boston Medical Center and Community Health Centers (CHCs); DotHouse CHC, South End Community Health Center, and Codman Square CHC) will be randomized to receive either text messages (TMs) regarding oral health or TMs regarding child wellness. The study will enroll English and Spanish speaking parents and their youngest child who is \< 7 years old, has at least one tooth showing, and attends the targeted pediatric clinic to receive primary care (n= 1700). Parents will complete self-report surveys at baseline, and 2, 4, 12, and 24-months after baseline; receive and respond to TM assessments during the 4-month intervention; and will also receive TMs during a 'booster' period of one month, which will occur 12-months post baseline. Parent's children will be assessed for caries by a clinical oral examination performed by licensed Clinical Examiners at baseline, 12-and-24-months post-baseline.
Interventions
- OTHER OHT Parent targeted text messages
- OTHER CWT Parent targeted text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2018-03-09 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03294590
The ClinicalTrials.gov registry entry for NCT03294590 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 754 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OHT Parent targeted text messages is the first listed.
NCT03294590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03294590 about?
NCT03294590 is a clinical study titled "Interactive Parent-Targeted Text Messaging in Pediatric Clinics to Reduce Caries Among Urban Children". This is a randomized clinical trial to test the efficacy of a parent-targeted text message-based intervention program on caries incidence and oral health behaviors (child and parent). Parents (n= 850) across all pediatric clinic sites (Boston Medical Center and Community Health Centers (CHCs); DotHo...
What is the current status of trial NCT03294590?
This trial is currently completed. It is a NA study. The enrollment target is 754 participants. The study started on 2018-03-09. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03294590?
The interventions under investigation include: OHT Parent targeted text messages (OTHER), CWT Parent targeted text messages (OTHER).
Who is sponsoring clinical trial NCT03294590?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.